Healthcare

This issue profiles an universal immune stimulatory peptide, site specific immunomodulators to cure inflammatory bowel disease and cancer, and a drug that is used to treat tumors can also target cancer stem cells.

This issue profiles a molecular pathway that holds the key to suppress children's cancer, destroying chemical weapons safely, and R&D on datacenter cabling at HP Laboratories.

This issue profiles an affordable and customisable radiotherapy system, a remote telerobotic ultrasound imaging platform, and affordable digital radiography systems for low-income countries.

This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

This issue profiles using an annuloplasty ring to treat mitral regurgitation, a novel leadless artificial cardiac pacemaker, and 3D printed medical devices that are on the rise.

This issue profiles a genome editing technology for treatment of blood cancer, a genetic risk assessment test for non-hereditary breast cancer, and rapid detection of infectious disease through innovations in molecular diagnostics.

This issue profiles a novel drug developed for treatment of insomnia, a drug for treating swimmer’s ear receives that FDA approval, and development of an advanced drug for chronic weight management.

This issue profiles experimental genetic mutation that cuts the risk of developing type 2 diabetes, identification of a novel biomarker for prostate cancer, and a drug metabolism test for epilepsy and seizure disorders.

Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2015. The research service provides an in depth analysis of the top 10 health and wellness technologies that are anticipated to have the highest impact a...